Zealand Pharma A/S. OverviewZealand Pharma A/S. EBIT
EBIT (Earnings Before Interest and Taxes) analysis for ZEAL.
Quarterly EBIT
-$302.00M
As of Mar 10, 2022
Annual EBIT (TTM)
-$1.14B
↓ 38.01% YoY
Trailing 12 months ending Mar 10, 2022
Zealand Pharma A/S. OverviewEBIT (Earnings Before Interest and Taxes) analysis for ZEAL.
As of Mar 10, 2022
Trailing 12 months ending Mar 10, 2022